GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (OTCPK:MBXBF) » Definitions » Issuance of Debt

MBXBF (Microbix Biosystems) Issuance of Debt : $0.02 Mil (TTM As of Jun. 2024)


View and export this data going back to . Start your Free Trial

What is Microbix Biosystems Issuance of Debt?

Microbix Biosystems's Issuance of Debt for the three months ended in Jun. 2024 was $0.00 Mil.

Microbix Biosystems's Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2024 was $0.02 Mil.

Microbix Biosystems Issuance of Debt Historical Data

The historical data trend for Microbix Biosystems's Issuance of Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbix Biosystems Issuance of Debt Chart

Microbix Biosystems Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Issuance of Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.86 0.56 0.50 0.80 1.14

Microbix Biosystems Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Issuance of Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.02 - - -

Microbix Biosystems Issuance of Debt Calculation

Issuance of Debt represents all the cash inflow from debt, including both long-term debt and short-term debt.

Issuance of Debt for the trailing twelve months (TTM) ended in Jun. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.02 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Microbix Biosystems Issuance of Debt Related Terms

Thank you for viewing the detailed overview of Microbix Biosystems's Issuance of Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

Microbix Biosystems Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Microbix Biosystems Inc (OTCPK:MBXBF) » Definitions » Issuance of Debt
Comparable Companies
TSX:HBP TSX:BCT XCNQ:DOSE TSXV:MIR TSXV:NRX TSXV:TTI XCNQ:MDMA XCNQ:DTC NEOE:BMND TSXV:GSD VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY BNTX XKRX:068270 BGNE
Traded in Other Exchanges
MBX:Canada
Address
265 Watline Avenue, Mississauga, ON, CAN, L4Z 1P3
Website
https://www.microbix.com
Microbix Biosystems Inc develops biological products and technologies. The company manufactures and develops cell culture-based biological products and technologies. It has developed and acquired two technologies; Kinlytic and LumiSort. The company's operating segment includes Antigen, QAPs DxTM and Other Includes Kinlytic. It generates maximum revenue from the Antigen QAPs segment. Geographically, it derives a majority of revenue from North America.